Muhammad Adnan Sabir Mughal | Pathobiology and Biomedical Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Adnan Sabir Mughal | Pathobiology and Biomedical Sciences | Best Researcher Award

Muhammad Nawaz Sharif University of Agriculture | Pakistan

Dr. Muhammad Adnan Sabir Mughal is a dedicated researcher and academic from Pakistan specializing in parasitology, with a strong focus on molecular surveillance of parasites affecting humans and livestock. He holds a Doctor of Veterinary Medicine, an MPhil in Parasitology, and is pursuing a PhD in Parasitology at the University of Agriculture, Faisalabad, where his work explores the epidemiology of equine trypanosomatids in Southern Punjab. His professional experience includes teaching and research as a lecturer at leading universities such as the University of Agriculture Faisalabad, Bahauddin Zakariyya University Multan, and MNS University of Agriculture Multan, as well as editorial roles as associate editor of Biological Times and editor for Unique Scientific Publisher. His research interests extend to food- and waterborne parasites, antiparasitic potential of natural extracts, and the application of bioinformatics in novel drug design against protozoan parasites. He possesses advanced technical skills in DNA and RNA extraction, PCR, sequence and phylogenetic analysis, as well as blotting techniques, alongside clinical and diagnostic expertise in animal health. He has been recognized with bronze and silver medals for academic excellence, university merit scholarships, and a Young Leaders Award by Volunteer Force Pakistan. Dr. Mughal’s strong academic record, research contributions, and leadership highlight his potential to advance parasitology through innovative and impactful approaches.

Profile: ORCID

Featured Publications

Noor Ul Ain | Genetics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Noor Ul Ain | Genetics | Best Researcher Award

Institute of Biomedical and Genetic Engineering | Pakistan

Noor Ul Ain is a highly accomplished molecular biologist whose academic journey reflects consistent excellence from her undergraduate studies in medical laboratory technology through advanced training in biochemistry, molecular biology, and culminating in a doctorate in molecular biology. Her professional career spans significant roles as a medical laboratory technologist at Shaukat Khanum Cancer Memorial Hospital, scientific officer, and later senior scientific officer at the Institute of Biomedical and Genetic Engineering in Islamabad, as well as a visiting PhD researcher at the Karolinska Institutet in Sweden. Her research interests focus on the genetics of rare skeletal disorders, genetic susceptibility to disease outcomes such as COVID, and broader studies in molecular genetics and clinical genomics. Skilled in a wide range of laboratory and analytical techniques, including next-generation sequencing, whole exome and genome data analysis, sanger sequencing, cell culture, cloning, immunofluorescence, and microscopy, she has contributed to numerous international publications with impactful findings in human genetics and molecular pathology. She has been recognized with several prestigious awards and scholarships, including distinctions for academic performance and international research fellowships. Noor Ul Ain stands out as a promising researcher whose contributions bridge clinical relevance with molecular discovery, and her dedication positions her as a leading figure in advancing genetic and biomedical sciences..

Profile: ORCID

Featured Publications

Qura Ain | Phamagenetics | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Qura Ain | Phamagenetics | Women Researcher Award

University College Dublin | Pakistan

Dr. Qura Tul Ain is a passionate pharmacogenetic researcher and medical doctor with a strong dedication to advancing knowledge in rare diseases, human genetics, and advanced health sciences. She completed her MBBS from the Services Institute of Medical Sciences in Lahore, where she gained extensive clinical exposure through rotations in medicine, surgery, intensive care, gynecology, and ophthalmology, and later pursued an MPhil in Pharmacology with a specialization in molecular genetics at Shifa Tameer-e-Millat University, Islamabad. Her academic training provided her with expertise in genomics, bioinformatics, and molecular pharmacology, with her thesis focusing on the pharmacogenetics of low-dose empagliflozin in patients with heart failure. Professionally, she has served as a demonstrator in pharmacology at Shifa College of Medicine, alongside clinical roles as a medical officer and house physician in both medicine and surgical departments. Her research interests include pharmacogenomics, molecular genetics, and personalized medicine, with a particular focus on identifying genetic markers that predict treatment outcomes in cardiovascular diseases. She is skilled in laboratory techniques such as PCR, RFLP, DNA/RNA extraction, and gel electrophoresis, which support her translational research. Her contributions have been recognized through research fellowships and academic opportunities, reflecting her commitment to bridging genetics and clinical therapeutics. With her strong foundation in medicine, research, and teaching, Dr. Qura Tul Ain is well positioned to make impactful contributions to precision medicine and healthcare innovation.

Profile: ORCID

Featured Publications

Chengfang Tang | Newborn Screening | Best Researcher Award

Published on by Cognitive Scientist Awards

Mrs. Chengfang Tang | Newborn Screening | Best Researcher Award

Guangzhou Medical University | China

Chengfang Tang, a supervising technician at Guangzhou Newborn Screening Center, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, holds a Master’s degree from Sun Yat-sen University with specialization in instrumental analysis in Pharmaceutical Analysis. With extensive professional experience, she has dedicated her career to clinical and research work on tandem mass spectrometry for newborn screening of multiple genetic metabolic diseases, contributing significantly to early detection and management of rare disorders. She also serves as Secretary of the Genetic Metabolism Group of the Rare Disease Branch of the Guangdong Medical Association, reflecting her leadership in the field. Her research interests center on newborn screening, with notable contributions in advancing diagnostic techniques for genetic metabolic conditions. She has published impactful research in high-quality journals, including International Journal of Neonatal Screening and Clinica Chimica Acta, and has conducted studies on newborn screening for adrenoleukodystrophy. Skilled in advanced laboratory techniques, mass spectrometry applications, and clinical data interpretation, her expertise supports precision medicine and improved child health outcomes. Recognized for her commitment, she has earned professional honors through memberships and leadership roles in scientific associations. Overall, Chengfang Tang’s work exemplifies excellence in research and innovation, strengthening global newborn screening efforts and improving pediatric healthcare.

Profile: ORCID

Featured Publications

Tanyanika Phillips | Care Delivery in Thoracic Oncology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Tanyanika Phillips | Care Delivery in Thoracic Oncology | Best Researcher Award

City of Hope National Med Center | United States

Dr. Tanyanika Phillips is an accomplished physician and academic leader specializing in thoracic and geriatric oncology. Currently serving as Assistant Professor in the Department of Medical Oncology and Therapeutics Research at City of Hope National Medical Center, she integrates patient care, research, and community health advocacy. Her professional journey reflects a steadfast dedication to improving cancer care across diverse populations, with a special focus on equity in access and outcomes. Throughout her career, she has held pivotal roles as a clinician, researcher, and administrator, contributing to health system development, rural oncology programs, and national initiatives in cancer equity. Known for her commitment to advancing inclusive research, Dr. Phillips has been instrumental in developing geriatric oncology services and clinical trials that address the needs of aging populations. Her career is distinguished by numerous leadership positions, prestigious awards, and recognition for her community-focused work in eliminating health disparities.

Profile

Scopus

Education

Dr. Tanyanika Phillips’ educational foundation reflects a balance of clinical excellence and population health. She earned her Bachelor of Science in Biology from Xavier University of Louisiana, followed by her Doctor of Medicine from the University of Rochester School of Medicine and Dentistry. Her interest in public health and health outcomes led her to pursue a Master of Public Health at Vanderbilt University, specializing in population-based studies and non-experimental design. She furthered her training through an internal medicine residency at Ochsner Clinic Foundation, a geriatric fellowship at Vanderbilt, and a prestigious medical oncology fellowship at the Sidney Kimmel Cancer Center at Johns Hopkins University. She also completed K12 Research training at Vanderbilt, emphasizing outcomes-based cancer research. Her executive education at Harvard School of Public Health and Case Western Reserve University enhanced her expertise in leadership, project management, and measurement design. This multidisciplinary academic preparation laid the groundwork for her career in oncology research, clinical innovation, and health equity.

Experience

Dr. Tanyanika Phillips has built a dynamic career across academic medicine, community oncology, and health equity leadership. She began as Assistant Professor at Case Western University, where she also directed the Health Equity Initiative in Cancer. Her dedication to accessible oncology care expanded during her tenure as a staff physician at St. John Medical Center and CHRISTUS Health, where she also served as Medical Director for Rural and Community Health. At Antelope Valley Hospital, she led the cancer program as Medical Director before joining City of Hope, where she has since shaped geriatric oncology programs, served as Site Research Champion, and directed community-focused cancer initiatives. In her current role, she balances clinical care and research, directing City of Hope’s Antelope Valley Cancer Program while advancing clinical trials in aging and thoracic oncology. Her leadership positions include Deputy Director of the Center for Cancer and Aging and Enterprise Champion for Advancing Inclusive Research.

Awards and Honors

Dr. Tanyanika Phillips’ career is marked by consistent recognition for excellence in medicine, leadership, and community service. Early in her journey, she received the Community of Caring Award from Ochsner Medical Foundation and the Futures Scholar distinction from the American Medical Directors Association. Her research potential was recognized with the American Society of Clinical Oncology Young Investigator Award. She has also been honored with a Certificate of Special Congressional Recognition for her leadership in Ohio. Her dedication to minority health and community empowerment was acknowledged through multiple awards, including the Unsung Hero Award from the North Coast Nurses Coalition and the Minority Faculty Development Award at University Hospitals Case Medical Center. At St. John Medical Center, she received Values in Action Awards for Human Dignity, Wisdom, and Presence. More recently, her contributions at City of Hope earned her the Values in Action Award for Collaboration and the 2025 Hope Colleague Award.

Research Focus

Dr. Tanyanika Phillips’ research interests are centered on thoracic oncology, geriatric oncology, and advancing equity in cancer care. She is particularly committed to designing and implementing clinical trials that address the unique needs of aging patients with cancer. Her work integrates population-based research methods, health outcomes assessment, and translational oncology to bridge gaps between laboratory advances and real-world applications. As a site research champion and program lead for geriatric oncology at City of Hope, she has facilitated community-based clinical trials aimed at improving access and participation among underrepresented populations. She is also deeply engaged in health equity research, focusing on reducing disparities in cancer outcomes through inclusive trial design and community navigation programs. Her leadership in advancing inclusive research has established her as a key figure in initiatives that integrate cancer biology, geriatrics, and population health, ensuring that scientific discoveries translate into equitable patient care.

 

Publications

 

Title: Clin-STAR Corner: Practice Changing Advances at the Interface of Oncology and Geriatrics
Year: 2025

Title: Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants
Year: 2025

Conclusion

Dr. Tanyanika Phillips stands as a distinguished oncologist, educator, and leader whose career reflects an enduring commitment to patient-centered care, health equity, and translational research, integrating clinical excellence with a vision for advancing inclusive and community-driven oncology practice.

Neha Verma | Biotechnology | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Neha Verma | Biotechnology | Best Researcher Award

Sharda University | India

Neha Verma is a dedicated biotechnology researcher currently pursuing her Ph.D. at Sharda University, research experience in molecular biology, cell culture, spectroscopy, and bioinformatics. She has significantly contributed to cancer and osteoporosis research, with numerous publications in reputed journals and several patents to her credit. Her expertise encompasses a range of technical proficiencies including FACS, RT-PCR, HPLC, GC-MS, LC-MS, NMR, FT-IR, and advanced microscopy. She has actively participated in multiple national and international conferences and workshops, earning recognition for her work. She has co-authored book chapters with reputed publishers like Elsevier and is the recipient of prestigious awards such as Best Oral Presentation, Best Research Scholar, Silver Medal, and Young Scientist Award. Neha’s research blends experimental biology with computational techniques, reflecting a multidisciplinary approach. With a commitment to innovation and translational research, she aims to make meaningful contributions to biomedical sciences through novel therapeutic strategies.

Profile

Googlescholar

 Education

Neha Verma has built a strong academic foundation in the life sciences and biotechnology domain. She is currently pursuing her Ph.D. in Biotechnology with coursework from the Department of Life Sciences at Sharda University, where her research involves a multidisciplinary approach combining cell culturing, phytochemical analysis, and bioinformatics modeling. Prior to this, she earned her M.Sc. in Biotechnology from Himalayan University, where she developed core competencies in laboratory techniques and research methodologies. She began her academic journey with a B.Sc. in Life Sciences, which laid the groundwork for her interest in molecular biology and biochemistry. Throughout her education, she has consistently demonstrated academic excellence, contributing to scientific publications, attending scientific forums, and actively engaging in workshops and webinars related to spectroscopy, AI tools in science, and genetic disorders. Her academic path reflects a progressive learning trajectory that aligns closely with her current research goals and future aspirations in translational biotechnology

Experience

Neha Verma possesses over five years of extensive hands-on research experience in biotechnology, particularly in molecular biology, animal cell culturing, and the isolation and application of plant-based bioactives. Her professional exposure spans several advanced analytical and spectroscopic platforms such as HPLC, GC-MS, LC-MS, NMR, and FT-IR, used primarily for metabolite profiling and compound identification. She has worked on osteogenic differentiation and anticancer studies using plant extracts, evidenced by her co-authorship on high-impact journal articles and patented innovations. She has cultivated skills in experimental planning, data analysis using GraphPad and Excel, and bioinformatics tools like molecular docking and Swiss target prediction. Neha has participated in several high-end workshops funded by DST-SERB and DBT, as well as training programs on good laboratory practices and 3D cell culture technology. Her experience also includes contributing to international book chapters and conference presentations, showcasing her commitment to knowledge dissemination and interdisciplinary research collaboration.

Awards and Honors

Neha Verma has earned multiple prestigious awards recognizing her research excellence and scientific contributions. She received the Best Oral Presentation Award at a DBT-funded National Conference focused on Disease Diagnosis and Drug Development.  she was honored with the Best Research Scholar Award at the 6th International Conference on Cutting-edge Solutions in Science, Technology, Engineering, and Humanities. Her achievements also include receiving the Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology. Additionally, she was conferred the Young Scientist Award at the 4th Annual Meeting of the International Association of Zoologists. These accolades reflect her sustained efforts in innovative biotechnology research, her impactful presentations at scientific forums, and her leadership in driving translational outcomes. Her work in cancer and osteoporosis research has consistently gained academic and peer recognition.

Research Focus

Neha Verma’s research is centered on biotechnology applications in cancer and osteoporosis, particularly through the use of plant-derived bioactive compounds. She investigates the therapeutic potential of phytochemicals on osteogenic differentiation and anticancer activity, integrating molecular biology techniques like RT-PCR and FACS with spectroscopic tools such as HPLC, GC-MS, LC-MS, and NMR for compound analysis. Her studies also extend to bioinformatics, where she employs molecular docking and target prediction to elucidate mechanistic pathways. Neha’s scientific approach is highly interdisciplinary, blending traditional ethnopharmacology with modern experimental and computational methods. Her work has led to several granted and published patents focusing on anticancer and anti-osteoporotic agents. With contributions to journals, conferences, and book chapters, she aims to bridge the gap between natural products research and clinical translational outcomes in biotechnology.

Publications

 

Title: Occupational health hazards and wide spectrum of genetic damage by the organic solvent fumes at the workplace: A critical appraisal
Year: 2022
Citations: 10

Title: Recent Update on Active Biological Molecules in Generating the Anticancerous Therapeutic Potential of Garcinia mangostana
Year: 2022
Citations: 9

Title: A review on therapeutic mechanism of medicinal plants against osteoporosis: effects of phytoconstituents
Year: 2023
Citations: 6

Title: Sustainable synthesis of magnetic nanoparticles: biological applications of Cedrus deodara extract
Year: 2025
Citations: 1

Conclusion

Neha Verma is an accomplished biotechnology researcher whose interdisciplinary expertise, impactful publications, patents, and awards reflect her commitment to advancing therapeutic innovations in cancer and osteoporosis through integrated experimental and computational approaches.

Buyani Ndlovu | Molecular and Cell Biology | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Buyani Ndlovu | Molecular and Cell Biology | Best Researcher Award

Buyani Ndlovu is a South African research scientist specializing in molecular biology, biotechnology, and microbiology. With a Ph.D. from the University of Cape Town, his groundbreaking doctoral work focused on developing plant-produced mRNA vaccines and novel expression vectors against avian viral diseases. Over the past decade, Buyani has honed a robust repertoire of molecular techniques and contributed significantly to academic research, teaching, and mentorship. He has held roles ranging from Research Scientist at Roche DIA to academic tutor and seminar organiser at UCT. His passion for scientific innovation is matched by his commitment to student development and community leadership. Through multiple scholarships and peer-reviewed publications, Buyani has demonstrated his academic excellence and research prowess. His work has been presented at numerous national and international conferences, highlighting his impact in both academia and applied science. A dedicated professional, he continues to push boundaries in vaccine research and recombinant protein expression technologies.

Profile

🎓 Education

Buyani Ndlovu holds a Ph.D. in Molecular & Cell Biology from the University of Cape Town, where he developed novel plant expression vectors and a plant-produced mRNA vaccine candidate against beak and feather disease virus. His MSc in Wine Biotechnology from Stellenbosch University focused on the identification and characterization of bacteriocins produced by wine-isolated LAB strains. He also completed a BSc Honours in Cell Biology and a BSc in Biological Sciences at the University of KwaZulu-Natal, where his undergraduate research investigated seed desiccation sensitivity and shell deformities in abalone. He has consistently secured competitive scholarships throughout his academic journey, including the CSIR-IBS, PRF, and NRF Doctoral Innovation Scholarships. Buyani’s academic background reflects a consistent trajectory of scientific curiosity, methodical investigation, and a multidisciplinary approach to molecular sciences. His academic excellence is further supported by his attendance at international workshops, such as the Oomycete Bioinformatic Training Workshop at Virginia Tech, enhancing his global research perspective.

🧪 Experience

Buyani Ndlovu currently serves as Scientist II at Roche DIA’s Reagent Research and Design department in Cape Town, contributing to enzyme engineering within the MethylSeq 2025 Project. From 2019 to 2024, he worked at the University of Cape Town as a tutor and laboratory demonstrator in molecular and cell biology, guiding students across various academic levels. His professional journey also includes chairing postgraduate seminars and extensive leadership in residence management at multiple universities. His doctoral research involved cloning, sequencing, and gene expression analysis for vaccine development. He has previously worked with Genestwister Africa as a molecular biology intern and served as a laboratory demonstrator at UKZN. His roles have combined scientific innovation with administrative coordination, mentorship, and public speaking. Notably, he also engaged in field research at Kruger National Park and has consistently been involved in organisational roles within academic residences, showcasing strong leadership and interpersonal skills across his career.

🏅 Awards and Honors

Buyani Ndlovu is the recipient of numerous prestigious academic awards and research scholarships. These include the CSIR-IBS Doctoral Scholarship (ZAR 140,000/year), PRF Doctoral Scholarship (ZAR 55,000/year), and UCT Doctoral Scholarship (ZAR 20,000/year) from 2019 to 2022. He was also awarded the NRF Doctoral Innovation Scholarship (ZAR 110,000/year) in 2015–2016. His early academic promise was recognized through the Technology Innovation Agency Scholarship (ZAR 70,000/year) in 2011–2012 and the Cape Biotech Scholarship (ZAR 50,000) in 2010. He received the USDA Travel Award Fellowship and the WhiteSci Travel Award Scheme to present his research internationally. In addition to financial accolades, his leadership has been recognized through elected roles in academic and student governance. His continuous recognition by multiple institutions underlines both his scholarly achievements and potential for continued excellence in bioscience innovation. These honors have significantly supported his academic trajectory and helped position him as a leader in molecular research.

🔬 Research Focus

Buyani Ndlovu’s research focus lies at the intersection of molecular biology, biotechnology, and microbiology, particularly in the development of plant-based vaccines and novel gene expression systems. His doctoral research introduced innovative replicating plant virus vectors and a plant-derived mRNA vaccine candidate to combat beak and feather disease virus in parrots. He is experienced in DNA/RNA manipulation, recombinant protein expression in plants, bacteria, and mammalian cells, and molecular assay techniques including PCR, ELISA, and Western blotting. His research has broader implications for low-cost vaccine development and sustainable pharmaceutical manufacturing using plant systems. Buyani has also contributed to plant-pathogen interaction studies, notably with Phytophthora cinnamomi, and is interested in functional genomics and synthetic biology. Currently, his work at Roche DIA involves enzyme engineering for diagnostic technologies. With his foundation in grant writing and research communication, he is well-placed to lead interdisciplinary projects that fuse molecular innovation with public health solutions.

✅ Conclusion

Buyani Ndlovu is a highly skilled research scientist with a rich background in molecular biology and biotechnology, marked by academic excellence, impactful research, and leadership. His contributions to plant-based vaccine development and molecular diagnostics highlight his scientific rigor and innovation. Combining technical proficiency with organizational and mentorship skills, he remains dedicated to advancing health sciences through cutting-edge research and collaborative engagement. With a vision to bridge academic knowledge and societal needs, Buyani aspires to transform lives through science. He stands out as a dynamic professional committed to excellence in research, teaching, and scientific leadership.

Publications

  • Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus

    2025-07-17 | Journal article
    CONTRIBUTORS: Buyani Ndlovu; Albertha R. van Zyl; Dirk Verwoerd; Edward P. Rybicki; Inga I. Hitzerot

  • Generation of composite Persea americana (Mill.) (avocado) plants: A proof-of-concept-study

    PLOS ONE
    2017-10-20 | Journal article
    DOI: 10.1371/journal.pone.0185896
    Part ofISSN: 1932-6203
    CONTRIBUTORS: S. Ashok Prabhu; Buyani Ndlovu; Juanita Engelbrecht; Noelani van den Berg

  • Screening, identification and characterization of bacteriocins produced by wine-isolated LAB strains

    Journal of Applied Microbiology
    2015-04 | Journal article
    DOI: 10.1111/jam.12752
    Part of ISSN: 1364-5072
    CONTRIBUTORS: B. Ndlovu; H. Schoeman; C.M.A.P. Franz; M. du Toit

Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Dr. Milana Frenkel-Morgenstern is an Israeli scientist and Principal Investigator at the Scojen Institute of Synthetic Biology, Reichman University. She specializes in bioinformatics, systems biology, and synthetic biology. With a rich background spanning molecular genetics, computer science, and structural biology, she has held key positions in institutions such as Bar-Ilan University, Weizmann Institute of Science, and the Spanish National Research Centre. She is renowned for her pioneering work in liquid biopsies, chimeric RNAs, and non-invasive diagnostic tools. Dr. Frenkel-Morgenstern has published extensively, served on prestigious evaluation panels, and received numerous fellowships and awards, including the Miguel Servet Fellowship and the Rector Prize for Scientific Innovation. Her leadership in both academic and public scientific communities, combined with a strong record of mentorship and university service, highlights her influential presence in biomedical research. She is also the founder of the “Art in Science” session at ISMB, reflecting her commitment to interdisciplinary innovation.

Profile

🎓 Education

Dr. Frenkel-Morgenstern earned her PhD in Molecular Genetics at the Weizmann Institute of Science under Prof. Shmuel Pietrokovski, specializing in bioinformatics and systems biology. Prior to that, she completed her MSc in Mathematics and Computer Science with a thesis in molecular biology from Bar-Ilan University, mentored by Prof. Ron Unger and Prof. Amihood Amir. Her undergraduate studies were also at Bar-Ilan University, where she earned a BSc in Mathematics and Computer Science. Her multidisciplinary education seamlessly blends life sciences, computational modeling, and mathematical analysis, forming the foundation for her later innovations in biomedical research. This strong computational background, coupled with a deep understanding of molecular biology, positioned her to excel in complex systems analysis, machine learning, and genomics, leading to a distinguished academic and research career. Her training has enabled her to lead translational biomedical projects, particularly in the fields of cancer research, structural bioinformatics, and synthetic biology.

🧪 Experience

Dr. Milana Frenkel-Morgenstern has over two decades of academic and research experience. She is currently Principal Investigator and Senior Lecturer at Reichman University. Prior to this, she was a senior faculty member at Bar-Ilan University’s Azrieli Faculty of Medicine for a decade. Internationally, she served as a staff scientist at the Spanish National Cancer Research Centre (CNIO) and was a postdoctoral fellow in the labs of Prof. Alfonso Valencia and Prof. Uri Alon. She has also been a scientific advisor and educator at the Weizmann Institute’s Davidson Institute. Dr. Frenkel-Morgenstern has taught a range of graduate-level courses in genomics, bioinformatics, and computational biology. She has been deeply involved in institutional governance, serving on data science boards, senate committees, and multiple departmental leadership roles. Her professional journey reflects a blend of research excellence, teaching dedication, and scientific outreach, including organizing the “Art in Science” initiative for ISMB/ECCB.

🏅 Awards and Honors

Dr. Frenkel-Morgenstern has received numerous prestigious awards recognizing her research and innovation. She was awarded the Rector Prize for Scientific Innovation by Bar-Ilan University in 2021, and the Bioinfo4Women Fellowship by the Barcelona Supercomputing Center from 2016–2019. Her work on RNA sequencing earned her the Miguel Servet Fellowship (2011–2015), and she received international postdoctoral fellowships from Caja Navarra Foundation and Horvitz Foundation. Her academic contributions have been recognized through several Travel Awards from ISMB, ECCB, and RECOMB, and she earned Outstanding Poster Awards in international conferences. As a guest editor for leading journals and evaluator for major funding bodies (ERC, ISF, GIF, etc.), her influence extends beyond research to shaping the global scientific agenda. She also received the Excellent Lecturer Award (2017) at Bar-Ilan University and serves as an academic reviewer and thesis evaluator for institutions across Israel, Europe, and Asia, demonstrating global academic leadership.

🔬 Research Focus

Dr. Frenkel-Morgenstern’s research centers on liquid biopsy technologies, cell-free nucleic acids (cfDNA/cfRNA), and systems and synthetic biology. Her lab investigates molecular biomarkers for cancer, arthritis, and prenatal diagnostics, developing computational platforms that utilize next-generation sequencing, AI, and machine learning. She explores chimeric RNAs, chromosomal translocations, and non-optimal codon usage, linking genetic regulation with disease mechanisms. Her interdisciplinary work bridges microbiome analysis, metagenomics, genome profiling, and protein-protein interaction networks, with translational applications in personalized medicine. In addition, she applies big data analytics to understand the cell cycle, identify druggable targets, and improve early diagnostics using non-invasive methods. Dr. Frenkel-Morgenstern is also investigating novel areas such as the relationship between melanin, Vitamin D, and mRNA technologies, relevant to both clinical and cosmetic science. Her research is both hypothesis-driven and data-intensive, aiming to convert large-scale biological data into practical medical insights and biotechnology solutions with significant societal impact.

✅ Conclusion

Dr. Milana Frenkel-Morgenstern is a leading scientist in bioinformatics and synthetic biology whose interdisciplinary research in liquid biopsies, systems biology, and AI-driven genomics continues to impact cancer diagnostics and translational medicine globally.

Publications

  • Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses

    Cancers
    2025-06 | Journal article | Author
    DOI: 10.3390/cancers17121901
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Dylan P. D’Souza; Eyal Yosefof; sharon tzelnick; Rajesh Detroja; Tal Wax; Adva Levy-Barda; Gideon Baum; Aviram Mizrachi et al.

  • ChiTaRS 8.0: the comprehensive database of chimeric transcripts and RNA-seq data with applications in liquid biopsy

    Nucleic Acids Research
    2025-01-06 | Journal article
    DOI: 10.1093/nar/gkae1126
    CONTRIBUTORS: Dylan DSouza; Lihi Bik; Olawumi Giwa; Shahaf Cohen; Hilit Levy Barazany; Tali Siegal; Milana Frenkel-Morgenstern

  • The applications of circulating cell-free DNA for oral squamous cell carcinoma patients as non-invasive diagnostics of structural variants, fusions and oncoviruses

    2023-11-30 | Preprint
    DOI: 10.1101/2023.11.29.23299177
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Eyal Yosefof; Sharon Tzelnick; Rajesh Detroja; Dylan P. D’Souza; Gidi Baum; Aviram Mizrachi; Gideon Bachar; Milana Frenkel Morgenster

Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Published on by Cognitive Scientist Awards

Dr. Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Academician/Research Scholar |COMSATS University Islamabad, Pakistan

Dr. Ishrat Mahjabeen is an accomplished molecular biologist and cancer geneticist currently serving as Associate Professor at COMSATS University Islamabad, with extensive expertise in head and neck cancer, gene regulation, and microRNA biology. She earned her PhD in Cancer Genetics from COMSATS and recently completed a prestigious Fulbright Postdoctoral Fellowship at Brown University, USA. Dr. Mahjabeen has over two decades of research and academic experience, contributing significantly to molecular oncology through her work on base excision repair pathway genes, miRNA dysregulation, and genetic polymorphisms. She has also been an active educator, having supervised numerous undergraduate and graduate students and taught a variety of bioscience courses. Her scholarly contributions include a Springer book chapter and multiple international conference presentations. With a deep commitment to cancer research and academic mentorship, she continues to shape the future of biomedical science in Pakistan and beyond through her innovative work and international collaborations.

Profile

🎓 Education

Dr. Ishrat Mahjabeen holds a diverse academic background rooted in biological sciences. She earned her Postdoctoral Research Fellowship (2023–2024) from Brown University, USA, through the esteemed Fulbright Scholarship Program. Her PhD in Cancer Genetics was awarded by COMSATS Institute of Information Technology Islamabad in 2013, where she conducted a thesis on deregulated base excision repair pathway genes and microRNAs in head and neck cancer. Prior to her doctorate, she completed her M.Phil. in Developmental Biology from Quaid-e-Azam University in 2006, focusing on methylcobalamin’s role in sciatic nerve regeneration in rabbits. Her academic journey began with an MSc in Zoology from the University of Arid Agriculture Rawalpindi in 2003, where she explored the impact of temperature on arthropod populations. This strong foundation across developmental biology, zoology, and cancer genetics has equipped her with a multi-dimensional understanding of complex biological systems, enabling her significant contributions to cancer research and biosciences education.

🧪 Experience

Dr. Ishrat Mahjabeen has over 20 years of rich research and academic experience in biosciences and molecular oncology. Since May 2024, she has been serving as Associate Professor at COMSATS University Islamabad, where she previously held the positions of Assistant Professor (2017–2024) and Senior Scientific Officer (2014–2017). Her academic journey began with research fellowships at leading institutions, including the Center for Molecular Biology of Oral Diseases at the University of Illinois at Chicago, Quaid-e-Azam University, and PMAS Arid Agriculture University. She also contributed as an honorary lecturer in Talagang. As a committed educator, she has supervised over 140 students across BS, MS, and PhD levels and has taught advanced courses in molecular biology, research techniques, and biochemistry. Her leadership in academia is marked by dedication to translational cancer research, curriculum development, and capacity building in the life sciences, fostering innovation and scientific rigor among emerging researchers.

🏅 Awards and Honors

Dr. Ishrat Mahjabeen has been honored with the prestigious Fulbright Postdoctoral Research Fellowship (2023–2024) at Brown University, USA—an international recognition of her excellence in cancer genetics research. Her academic achievements and research impact have earned her continued faculty promotions within COMSATS University Islamabad, reflecting her contributions to teaching, student mentorship, and scientific leadership. She has received recognition for her work through invited talks and presentations at notable global scientific platforms, including the American Association of Extracellular Vesicles (AAEV 2023) in Boston and multiple international conferences in Turkey and Pakistan. Her chapter contribution in a Springer book on head and neck cancer highlights her thought leadership in molecular oncology. These accolades underscore her pioneering work in cancer biology, particularly in miRNA and gene regulation research, as well as her role in fostering academic excellence and collaborative innovation across borders.

🔬 Research Focus

Dr. Ishrat Mahjabeen’s research centers on molecular oncology with a focus on genetic and epigenetic mechanisms underlying cancer development, particularly head and neck cancers. Her PhD work explored deregulated base excision repair pathway genes and the role of microRNAs in tumor progression. She investigates how miRNA dysregulation, gene polymorphisms, and checkpoint kinase alterations contribute to tumorigenesis, with significant emphasis on gliomas, gastric cancer, and H. pylori-associated pathogenesis. Dr. Mahjabeen is also involved in studying exosomal miRNAs and their functional targets, aiming to identify biomarkers and therapeutic targets. Her translational research approach integrates molecular biology with bioinformatics to unravel cancer pathways and personalize treatment strategies. Her postdoctoral research at Brown University further broadened her scope, allowing global collaborations and access to advanced genomic tools. She remains committed to bridging basic research and clinical relevance to improve early cancer diagnostics and targeted therapies in low-resource healthcare settings.

✅ Conclusion

Dr. Ishrat Mahjabeen stands out as a dynamic academic and cancer researcher, combining excellence in teaching, mentorship, and cutting-edge molecular oncology. Her global exposure, leadership in translational research, and unwavering commitment to biosciences make her an asset to the scientific community.

4o
Publications

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675